1. 输入关键词后点击检索按钮可查询指定关键词在语料中的对应情况
  2. 选择语种可限定关键词的语言,当前支持中文和英文,默认选择中文
  3. 主题选项中可限定检索语料的文章主题范围,默认全部主题
  4. 主题选项中可限定检索语料的文本类型范围,默认全部类型
  5. 在结果列表中,点击操作栏中的“查看中文全文”或“查看英文全文”按钮可查看该句所在的中文语料全文
句对齐列表 共 16269 个结果  
序号 中文 英文 操作
10681 值此之际世界卫生组织(世卫组织)组织了一次线上全球会议,包括: On this occasion, the World Health Organization (WHO) organized a virtual global conference that featured:
10682 全球患者安全领导者和倡导者的主旨演讲 keynote addresses by global patient safety leaders and advocates;
10683 孕产妇新生儿健康与安全全球概况和来自一线的故事; global landscape and stories from the ground on maternal and newborn health and safety;
10684 关于在实现全民健康覆盖的征程中优先考虑孕产妇和新生儿医疗照护安全以及合作伙伴作用的小组讨论; panel discussions on prioritizing safety in maternal and newborn care on the journey towards universal health coverage, and the role of partners;
10685 发布2021年世界患者安全日目标 launch of World Patient Safety Day Goals 2021.
10686 全球疫苗安全咨询委员会对阿斯利康COVID-19疫苗(Vaxzevria和Covishield)罕见不良凝血事件的最新证据的审查 Global Advisory Committee on Vaccine Safety (GACVS) review of latest evidence of rare adverse blood coagulation events with AstraZeneca COVID-19 Vaccine (Vaxzevria and Covishield)
10687 2021年4月16日 | 声明 16 April 2021 | Statement
10688 据报告,在Vaxzevria和Covishield COVID-19疫苗接种后,发生了一种非常罕见的新型不良事件,称为血栓性血小板减少综合征,涉及伴有血小板计数偏低的异常和严重凝血事件。 A very rare new type of adverse event called Thrombosis with Thrombocytopenia Syndrome (TTS), involving unusual and severe blood clotting events associated with low platelet counts, has been reported after vaccination with COVID-19 Vaccines Vaxzevria and Covishield.
10689 布莱顿协作组 1 正在制订血栓性血小板减少综合征的具体病例定义 A specific case definition for TTS is being developed by the Brighton Collaboration 1 .
10690 这将有助于确定评价报告的血栓性血小板减少综合征事件,并协助支持因果关系评估。 This will assist in identifying and evaluating reported TTS events and aid in supporting causality assessments.